title: Circulating biomarkers that predict incident dementia.
abstract: Dementia is currently diagnosed based on clinical symptoms and signs, but significant brain damage has already occurred by the time a clinical diagnosis of dementia is made, and it is increasingly recognized that this may be too late for any effective intervention. It would therefore be of great public health and preventive value to define a variety of biomarkers that could permit early detection of persons at a higher risk for developing dementia, and specifically dementia due to Alzheimer's disease. Nevertheless, for the purpose of large-scale screening, circulating biomarkers are more appropriate because they are less invasive than lumbar puncture, less costly than brain amyloid imaging and can be easily assessed repeatedly in a primary care clinic setting. In this brief review we will review a number of candidate molecules implicated as possible predictors of dementia risk. These candidates include markers of vascular injury, metabolic and inflammatory states, amyloid and tau pathway markers, measures of neural degeneration and repair efforts, and other molecules that might contribute to anatomical and functional changes characteristic of dementia and Alzheimer's disease.
authors.affiliation: Department of Neurology, Boston University School of Medicine, B602, 72 East Concord Street, Boston, MA 02118, USA ; Framingham Heart Study, 73 Mount Wayte Avenue, Framingham, MA 01702, USA.
authors.forename: Galit
authors.initials: G
authors.lastname: Weinstein
authors.affiliation: Department of Neurology, Boston University School of Medicine, B602, 72 East Concord Street, Boston, MA 02118, USA ; Framingham Heart Study, 73 Mount Wayte Avenue, Framingham, MA 01702, USA.
authors.forename: Sudha
authors.initials: S
authors.lastname: Seshadri